Journal of Analytical Toxicology

Papers
(The TQCC of Journal of Analytical Toxicology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Correction to: Can PEth be detected with a cutoff of 20 ng/mL after single alcohol consumption?68
From promise to practice: why HRMS has yet to fully revolutionize forensic toxicology61
A comparison of vitreous fluid and blood matrices in postmortem drug analysis45
Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC–HRMS-MS39
Fatal Rectal Injection of 3-MMC in a Sexual Context: Toxicological Investigations Including Metabolites Identification Using LC–HRMS37
UHPLC–MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers29
Identification of 4F-MDMB-BICA using a molecular network strategy in a case of severe poisoning with coma26
Cork sheet as an efficient biosorbent for forensic toxicology: Application to vitreous humor analysis25
A Fatal Case Report of Barium Chloride Toxicity25
Correction to: Cross-reactivity of 24 cannabinoids and metabolites in blood using the Immunalysis Cannabinoids Direct enzyme-linked immunosorbent assay23
Suitability of SoToxa® Oral Fluid Screening Over Time: Re-Examination of Drugged Driving in Wisconsin19
Development and Validation of a DLLME–GC–MS-MS Method for the Determination of Benzotriazole UV Stabilizer UV-327 and Its Metabolites in Human Blood17
Preanalytical Factors Influencing the Stability of Ethanol in Antemortem Blood and Urine Samples17
Fatal Intoxications from a Combination of 4-Fluoroamphetamine and 25C-NBOMe17
Exploring transdermal SARMs exposure: analysis of the elimination profiles and metabolism for doping control purposes16
2-Fluorodeschloroketamine consumption: About two deaths and a case of self-mutilation16
LC–MS-MS quantification of Δ8-THC, Δ9-THC, THCV isomers and their main metabolites in human plasma15
The impact of vaping ethanol-containing electronic cigarette liquids on roadside impairment investigations15
A novel screening workflow for nitazene analogs using LC-MS/MS precursor ion scan acquisition15
Correction to: α-Pyrrolidinohexanophenone (α-PHP) vs. α-pyrrolidinoisohexanophenone (α-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases15
A postmortem case report involving fentanyl, desalkylgidazepam, and bromazolam15
Automated extraction and LC–MS-MS analysis of 11-nor-9-carboxy-tetrahydrocannabinol isomers and prevalence in authentic urine specimens14
β′-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology14
Detection of thiocyanate in postmortem blood of a fatal potassium thiocyanate-poisoning patient using gas chromatography–mass spectrometry14
Fatal concentrations of antidepressant and antipsychotic drugs in postmortem femoral blood14
Correction to: UHPLC–MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers14
The evolution of fentanyl-related substances: Prevalence and drug concentrations in postmortem biological specimens at the Miami-Dade Medical Examiner Department13
Solriamfetol and m-chlorophenylpiperazine cause false positive amphetamine results on urine drug screening13
Deaths involving novel benzodiazepines in Victoria, Australia from 2018 to 202213
Estimation of Delta-8 Tetrahydrocannabinol (THC) Concentrations in DUID Investigation Casework13
The First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the Literature13
Toxicological and demographic profiles of phencyclidine-impaired driving cases in Houston: updates from the 2019 to 2023 data12
Supporting evidence for 5-acetamido-N-desethylmetonitazene as a potential metabolite rather than a degradation product12
A False-Positive Gamma-Hydroxy Butyric Acid Urine Screening in a Patient with High Anion Gap Metabolic Acidosis Due to Ethylene Glycol Poisoning12
Fatal Intoxication by the Novel Cathinone 4-Fluoro-3-methyl-α-PVP11
Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products11
Fast and Sensitive Method for the Determination of 17 Designer Benzodiazepines in Hair by Liquid Chromatography–Tandem Mass Spectrometry11
Long-term stability of sufentanil quantified by UPLC–MS–MS in human plasma frozen for 11 years at −20°C11
Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA)10
The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC–QTOF-MS and synthesized reference standards10
The emergence of bromazolam in Jefferson County, AL: a case series10
Segmental analysis and long-term monitoring of vadadustat in equine hair for the purpose of doping control10
Society of Forensic Toxicologists, Inc.10
∆8-THC, THC-O Acetates and CBD-di-O Acetate: Emerging Synthetic Cannabinoids Found in Commercially Sold Plant Material and Gummy Edibles10
A Comparison of High Drug Concentrations in Impaired Driving and Postmortem Casework in Harris County, TX10
The Stability of Synthetic Cathinones and the Study of Potential Intake Biomarkers in the Biological Material from a Case of 3-CMC Poisoning10
Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography–high-resolution tandem mass spectrometry10
Evaluation of sevoflurane interference with forensic blood ethanol analysis, including sevoflurane stability, and an authentic case10
Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters9
The rising trend of MDPHP consumption: an Italian snapshot9
Dubowski’s stages of alcohol influence and clinical signs and symptoms of drunkenness in relation to a person’s blood-alcohol concentration—Historical background9
Ethanol stability from 9 years of a blind quality control program in blood alcohol analysis9
Medetomidine quantitation and enantiomer differentiation in biological specimens collected after fatal and non-fatal opioid overdoses9
SIGNIFY™ ER tricyclic antidepressant false positives in diphenhydramine overdose cases9
Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 20218
Toxicological evaluation, postmortem case descriptions, and pharmacological activity of N,N-dimethylpentylone and related analogs8
A highly sensitive headspace gas chromatographic method fully optimized for fast routine determination of carboxyhemoglobin in postmortem blood8
Update on Urine Adulterants and Synthetic Urine Samples to Subvert Urine Drug Testing8
Green Analytical Toxicology procedure for determination of ketamine, its metabolites and analogues in oral fluid samples using dispersive liquid–liquid microextraction (DLLME)8
Increase of PEth after Single Consumption of Alcohol and Evaluation of a Volumetric DBS Filter Paper Device8
Brain concentrations and brain–blood ratios of amitriptyline and nortriptyline in forensic postmortem cases8
Interference of the novel designer benzodiazepine 4ʹ-chloro deschloroalprazolam with alprazolam analysis in toxicology and seized drug DUID casework8
Preparation and stability characterization of flavour ingredients in E-liquids for preclinical assessment of electronic nicotine delivering system products: a case study of 38 flavour ingredients in a8
Quantitation of hexahydrocannabinol (HHC) and metabolites in blood from DUID cases8
Cross-reactivity of 24 cannabinoids and metabolites in blood using the Immunalysis Cannabinoids Direct enzyme-linked immunosorbent assay8
Driving under the Influence of Amphetamine: Analytical Evaluation of Illegal or Prescription Drug Intake Using Chiral UHPLC–MS-MS8
Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography–tandem mass spectrometry8
Analysis of cannabinoids and semi-synthetic cannabinoids in authentic breastmilk samples by liquid chromatography–tandem mass spectrometry8
Adsorption of Therapeutic and Recreational Drugs During Prolonged Storage of Plasma Samples in Gel Separator Tubes8
Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol7
Correction to: Drug detection in oral fluid and urine after single therapeutic doses of dexamphetamine, lisdexamphetamine, and methylphenidate in healthy volunteers7
Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City7
Identification of 5-aminometonitazene and 5-acetamidometonitazene in a postmortem case: are nitro-nitazenes unstable?7
Designer Benzodiazepines Gidazepam and Desalkygidazepam (Bromonordiazepam): What Do We Know?7
Toxicology testing in the USA: what the 2018 census of medical examiner and coroner offices tells us7
Comparisons of blood alcohol concentrations between initial testing and reanalysis from unopened tubes preserved with 0.25% NaF following refrigerated storage up to 3.93 years7
Confirmation of cannabinoids in forensic toxicology casework by isomer-selective UPLC–MS-MS analysis in urine7
Comprehensive LC–MS-MS analysis of THC isomers, analogs, homologs, and metabolites in blood and urine7
Quantification of daridorexant, lemborexant, and suvorexant in whole blood using liquid chromatography–tandem mass spectrometry7
Development of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Simultaneous Determination of 40 Drugs of Abuse in Human Urine: Application to Real Cases7
Correction to: Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users7
Potential exhaled breath biomarkers identified in chlorine-exposed mice6
Chlorthalidone in vitro metabolite identification for documenting exposure in doping6
Reclassification of Pregabalin in the UK: Has It Made a Difference in Deaths?6
Lethal carbon monoxide generated from small internal combustion engines6
Development of a Dispersive Liquid–Liquid Microextraction for Synthetic Cathinones in Biological Fluids Based on Principles of Green Analytical Toxicology6
Quantitative Analysis of Lysergic Acid Diethylamide and Metabolite in Urine by Automated Extraction and Liquid Chromatography–Tandem Mass Spectrometry6
Hydroxyzine in impaired driving investigations6
Oral fluid device performance in identifying amphetamine, methamphetamine, and cocaine use in Brazilian drivers6
Pulverization Is a Crucial Step—A Comparative Study of Different Pretreatments in Hair Drug Testing6
Intralipid as a matrix additive for evaluating hyperlipidemic postmortem blood6
Green Analytical Toxicology for the Determination of Cocaine Metabolites6
The detection of delta-9-tetrahydrocannabinol, delta-8-tetrahydrocannabinol, delta-10-tetrahydrocannabinol, and cannabidiol in hair specimens6
Four-year evaluation of drug-impaired driving drug concentrations6
Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 20206
ANSI/ASB Standards 119, 120 and 121 Set Minimum Analytical Scope and Sensitivity for Subdisciplines of Forensic Toxicology6
Performance of Hair  Testing for Cocaine Use—Comparison of Five Laboratories Using Blind Reference Specimens6
Pregabalin concentrations: establishing ‘normal’ and ‘cause for concern’ concentration ranges in postmortem blood6
Cross-reactivity in urine of 53 cannabinoid analogs and metabolites using a carboxylic acid enzyme-linked immunosorbent assay (ELISA) and homogenous enzyme immunoassay (HEIA) kit and immunalysis synth6
Postmortem concentrations for total blood carbon monoxide (TBCO) as a novel biomarker for carbon monoxide (CO) poisonings6
Fentanyl as a marker of illicit drug use in morphine-positive urine specimens from workplace drug testing6
A fully validated LC–QTOF-MS screening workflow for the analysis of drugs in oral fluid6
Development and method validation of a sampling technique for a reproducible detection of synthetic cannabinoids in exhaled breath using an in vitro pig lung model6
Distribution of quetiapine between serum and whole blood in therapeutic drug-monitoring specimens6
North America laboratory survey data for drug testing in drug-impaired driving and traffic fatality investigations6
Analysis, Stability and Distribution of Pharmaceuticals and Drugs of Abuse over a Period of One Year in Formalin-Fixed Liver and Formalin Solutions6
A New Multi-Analyte LC–MS-MS Screening Method for the Detection of 120 NPSs and 49 Drugs in Hair6
Simultaneous analysis of acyclovir and its metabolite using hydrophilic interaction liquid chromatography–tandem mass spectrometry6
Toxicological detection of the new psychoactive substances MDPHP and MDPHpP in human urine samples by elucidation of their urinary metabolites using gas chromatography–mass spectrometry6
Use of Liquid Chromatography--Tandem Mass Spectrometry to Quantify and Confirm the Fentanyl MetaboliteN-[1-(2-Phenethy-4-Piperidinyl)] Maloanilinic Acid in Equine Urine for Doping Control6
0.44299507141113